Related references
Note: Only part of the references are listed.Independent and Combined Effects of Exercise Training and Metformin on Insulin Sensitivity in Individuals With Prediabetes
Steven K. Malin et al.
DIABETES CARE (2012)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Novel developments in omega-3 fatty acid-based strategies
Michael H. Davidson et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study
H. A. W. Neil et al.
ATHEROSCLEROSIS (2010)
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus
Martijn C. G. J. Brouwers et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome
Shalini V. Kaushik et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Prescription Omega-3-Acid Ethyl Esters for the Treatment of Very High Triglycerides
Richard Sadovsky et al.
POSTGRADUATE MEDICINE (2009)
Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia
Philip Barter et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects
Peter J. H. Jones et al.
LIPIDS IN HEALTH AND DISEASE (2007)
Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study
Francesca Vittone et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2007)
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate
Dimitrios S. Christidis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines
SM Grundy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
L Calabresi et al.
ATHEROSCLEROSIS (2000)
Share Paper
